Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spinal Anesthesia and Etomidate for Loss of Consciousness
NCT03240055Completed
- Sponsor
- General Hospital of Ningxia Medical University
- Start
- Jun 2017
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of etomidate, sponsored by General Hospital of Ningxia Medical University. Primary endpoints: Median effective dose of etomidate at 4 minutes and Bispectral Index value at 50% probability of loss of consciousness at 4 minutes. Started Jun 2017; status: completed.
02
Drugs
etomidate
Beyond the preview
Go deeper on NCT03240055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03240055.